You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康泰生物(300601.SZ):吸附無細胞百白破(組分)聯合疫苗開啟Ⅲ期臨牀試驗
格隆匯 05-30 16:01

格隆匯5月30日丨康泰生物(300601.SZ)公佈,公司全資子公司北京民海生物科技有限公司研發的吸附無細胞百白破(組分)聯合疫苗已完成Ⅲ期臨牀試驗準備工作,開啟Ⅲ期臨牀試驗,並於今日成功完成首例受試者入組。

吸附無細胞百白破(組分)聯合疫苗適用於2月齡及以上的嬰幼兒,接種本疫苗後,可使機體產生免疫應答,用於預防百日咳、白喉、破傷風。該疫苗中的百日咳抗原可精確定量,保證有效成分的批間一致性。

經查詢國家藥品監督管理局網站,目前國內廠家暫無吸附無細胞百白破(組分)聯合疫苗的產品獲批上市。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account